Patchd, INC R & D for clinical validation of an at-home, deep-learning based, sepsis monitoring system AOI#2 infection severity & solving sepsis
Ended Definitive Contract Awarded Last action
- Contract number
- 75A50122C00059
- Awardee
-
Cytovale Inc. UEI TG7HM4HD8594
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $437,799
Award facts
- Opportunity
-
- BARDA's Division of Research, Innovation & Ventures (DRIVe) Easy Broad Agency Announcement Solicitation · BAA20100SOL0002 · Posted Feb 3, 2020
- Contract value 100% obligated
- $437,799.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Basic Research
- Pricing
- Firm Fixed Price
- Place of performance
- San Francisco, CA 94104, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$30,306 | |
| Supplemental Agreement for work within scope | $0 | |
| Novation Agreement | -$281,571 | |
| Supplemental Agreement for work within scope | $0 | |
| Vendor DUNS or Name Change - Non-Novation | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $749,676 |
About this award
The U.S. Department of Health and Human Services (HHS), Office of the Assistant Secretary for Preparedness and Response (ASPR), awarded a $437,799.02 firm-fixed-price contract to Cytovale Inc., a small disadvantaged business, to conduct research and development for the clinical validation of an at-home, deep-learning based sepsis monitoring system. This contract is part of ASPR's Biomedical Advanced Research and Development Authority (BARDA) Easy Broad Agency Announcement (EZ-BAA) focused on detecting, managing, and treating infectious diseases like sepsis. The award supports Cytovale's efforts to advance its biophysical early sepsis diagnostic technology towards U.S. Food and Drug Administration (FDA) clearance. Cytovale has previously received ASPR funding to evaluate the impact of its IntelliSep test on clinical decision-making and sepsis risk stratification.
Quick answers
Who was awarded contract 75A50122C00059?
75A50122C00059 was awarded to Cytovale Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 28, 2022.
How much is contract 75A50122C00059 worth?
The government has obligated $437,799 on 75A50122C00059.
Was contract 75A50122C00059 competed?
The extent of competition for 75A50122C00059 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award